Diabetes pill may also fortify fragile bones
NCT ID NCT06050577
Summary
This study is testing whether a daily pill called oral semaglutide, already used for type 2 diabetes, can also improve bone health. It will involve 64 adults aged 50-85 who have both type 2 diabetes and an increased risk of bone fractures. Participants will take either the real medication or a placebo for one year, and researchers will measure changes in bone strength and quality using blood tests, scans, and other bone health assessments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Odense University Hospital
Odense, 5000, Denmark
Conditions
Explore the condition pages connected to this study.